AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Apimeds Pharmaceuticals US, Inc

$3.01 -$13.69 (-81.98%)
AMEX · 30 Oct 2026 20:00 UTC
Previous Close
$3.21
Day Range
$2.85$3.11
Year Range
$1.51$59.70
Market Cap
4.54M
AVG Volume
2.72M
Trailing/Forward PE
-0.06/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
New York Stock Exchange ArcaUS
Net Income (USD) · A
-8M-6M-4M-2M0202320242025
APUS Net Income (USD) by year
PeriodNet Income (USD)
2025-6M
2024-1.39M
2023-777.69K
Operating Income (USD) · A
-15M-10M-5M0202320242025
APUS Operating Income (USD) by year
PeriodOperating Income (USD)
2025-11.91M
2024-1.28M
2023-747.44K
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: APUS

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

Apimeds Pharmaceuticals US, Inc
APUS
Stockpicker

Video analysis: APUS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: APUS

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.